Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1979;60:1360-1364

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prystowsky, E. N.
Right arrow Articles by Gallagher, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prystowsky, E. N.
Right arrow Articles by Gallagher, J.

Circulation, Vol 60, 1360-1364, Copyright © 1979 by American Heart Association


ARTICLES

The natural history of conduction system disease in myotonic muscular dystrophy as determined by serial electrophysiologic studies

EN Prystowsky, EL Pritchett, AD Roses and J Gallagher

To evaluate the progression of conduction system disease in myotonic muscular dystrophy, nine patients underwent serial electrophysiologic studies at a mean of 35 months apart. At the initial study, seven patients had first-degree atrioventricular block and three of these seven had disease in the His-Purkinje system (HV greater than 55 msec). At the second study, seven patients had prolonged HV intervals, and during the almost 3-year period, HV intervals increased by at least 5 msec in all seven patients. No electrophysiologic or electrocardiographic measures could be found that correlated with progression of conduction disease in these patients. Because of the failure of electrophysiologic measures to predict progression of conduction disease in these patients, electrophysiologic studies are recommended only for symptomatic patients. If significant disease is found in either impulse formation or conduction, permanent pacemaker therapy is warranted.


This article has been cited by other articles:


Home page
HeartHome page
G Pelargonio, A D. Russo, T Sanna, G De Martino, and F Bellocci
MYOTONIC DYSTROPHY AND THE HEART
Heart, December 1, 2002; 88(6): 665 - 670.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Lazarus, J. Varin, D. Babuty, F. Anselme, J. Coste, and D. Duboc
Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing: A multicenter diagnostic pacemaker study
J. Am. Coll. Cardiol., November 6, 2002; 40(9): 1645 - 1652.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
D Babuty, L Fauchier, D Tena-Carbi, P Poret, J Leche, M Raynaud, J P Fauchier, and P Cosnay
Is it possible to identify infrahissian cardiac conduction abnormalities in myotonic dystrophy by non-invasive methods?
Heart, November 1, 1999; 82(5): 634 - 637.
[Abstract] [Full Text]


Home page
CirculationHome page
A. Lazarus, J. Varin, Z. Ounnoughene, H. Radvanyi, C. Junien, J. Coste, P. Laforet, B. Eymard, H. M. Becane, S. Weber, et al.
Relationships Among Electrophysiological Findings and Clinical Status, Heart Function, and Extent of DNA Mutation in Myotonic Dystrophy
Circulation, March 2, 1999; 99(8): 1041 - 1046.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M.F. Phillips and P.S. Harper
Cardiac disease in myotonic dystrophy
Cardiovasc Res, January 1, 1997; 33(1): 13 - 22.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Maeda, C. S. Taft, E. W. Bush, E. Holder, W. M. Bailey, H. Neville, M. B. Perryman, and R. D. Bies
Identification, Tissue-specific Expression, and Subcellular Localization of the 80- and 71-kDa Forms of Myotonic Dystrophy Kinase Protein
J. Biol. Chem., September 1, 1995; 270(35): 20246 - 20249.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. A. Brink, A. Ferreira, J. C. Moolman, H. W. Weymar, P.-L. van der Merwe, and V. A. Corfield
Gene for Progressive Familial Heart Block Type I Maps to Chromosome 19q13
Circulation, March 15, 1995; 91(6): 1633 - 1640.
[Abstract] [Full Text]


Home page
NEJMHome page
L. J. Ptacek, K. J. Johnson, and R. C. Griggs
Genetics and Physiology of the Myotonic Muscle Disorders
N. Engl. J. Med., February 18, 1993; 328(7): 482 - 489.
[Full Text]


Home page
ANN INTERN MEDHome page
M. R. Milner, R. J. Hawley, M. Jachim, J. Lindsay Jr., and R. D. Fletcher
Ventricular Late Potentials in Myotonic Dystrophy
Ann Intern Med, October 15, 1991; 115(8): 607 - 613.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
A. D. Roses
Myotonic Muscular Dystrophy: From Clinical Description to Molecular Genetics
Arch Intern Med, August 1, 1985; 145(8): 1487 - 1492.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
R. J. Hawley, J. S. Gottdiener, J. A. Gay, and W. K. Engel
Families With Myotonic Dystrophy With and Without Cardiac Involvement
Arch Intern Med, November 1, 1983; 143(11): 2134 - 2136.
[Abstract] [PDF]